Sclerosing cholangitis

被引:14
作者
Maggs, James R. L. [1 ]
Chapman, Roger W. [1 ]
机构
[1] John Radcliffe Hosp, Dept Gastroenterol, Oxford OX3 9DU, England
关键词
cholangiocarcinoma; orthotopic liver transplantation; primary sclerosing cholangitis; ursodeoxycholic acid;
D O I
10.1097/MOG.0b013e32805867e6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by strictures of the biliary tree complicated by cirrhosis and cholangiocarcinoma. It is immune mediated, although the precise aetiology remains unknown. Recent findings Research into etiopathogenesis and epidemiology, diagnosis of cholangiocarcinoma, associations with inflammatory bowel disease and autoimmune pancreatitis, and medical therapy are discussed. Summary Multiple gene polymorphisms associated with primary sclerosing cholangitis have been investigated. Common inflammatory bowel disease-associated polymorphisms do not confer any susceptibility to primary sclerosing cholangitis; the role of intercellular adhesion molecule-1 gene polymorphisms and CCR5 mutations remain unclear. Elevated IgG4 has been demonstrated in a subgroup of primary sclerosing cholangitis patients, which may indicate an overlap with autoimmune pancreatitis and possible responsiveness to steroids. Biliary brush cytology may assist in diagnosis of cholangiocarcinoma, although further clinical indicators are required. Animal studies suggest the superiority of 24-norursocleoxycholic acid over ursodeoxycholic acid in reducing histological disease progress; translational studies in humans are now required.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 52 条
[1]   Sclerosing cholangitis: A focus on secondary causes [J].
Abdalian, Rupert ;
Heathcote, E. Jenny .
HEPATOLOGY, 2006, 44 (05) :1063-1074
[2]   Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease [J].
Adams, DH ;
Eksteen, B .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (03) :244-251
[3]   Chemotherapy-induced sclerosing cholangitis: Long-term response to endoscopic therapy [J].
Alazmi, WM ;
McHenry, L ;
Watkins, JL ;
Fogel, EL ;
Schmidt, S ;
Sherman, S ;
Lehman, GL .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (04) :353-357
[4]   Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? [J].
Awadallah, NS ;
Chen, YK ;
Piraka, C ;
Antillon, MR ;
Shah, RJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) :284-291
[5]   Primary sclerosing cholangitis can present with acute liver failure:: Report of two cases [J].
Bergquist, A ;
Glaumann, H ;
Lindberg, B ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2006, 44 (05) :1005-1008
[6]   Perinatal events and the risk of developing primary sclerosing cholangitis [J].
Bergquist, Annika ;
Montgomery, Scott M. ;
Lund, Ulrika ;
Ekbom, Anders ;
Olsson, Rolf ;
Lindgren, Stefan ;
Prytz, Hanne ;
Hultcrantz, Rolf ;
Broome, Ulrika .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (37) :6037-6040
[7]   Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis [J].
Berstad, AE ;
Aabakken, L ;
Smith, HJ ;
Aasen, S ;
Boberg, KM ;
Schrumpf, E .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (04) :514-520
[8]   Liver transplantation in primary sclerosing cholangitis [J].
Bjoro, Kristian ;
Brandsaeter, Bjorn ;
Foss, Aksel ;
Schrumpf, Erik .
SEMINARS IN LIVER DISEASE, 2006, 26 (01) :69-79
[9]   Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis [J].
Boberg, Kirsten Muri ;
Jebsen, Peter ;
Clausen, Ole Petter ;
Foss, Aksel ;
Aabakken, Lars ;
Schrumpf, Erik .
JOURNAL OF HEPATOLOGY, 2006, 45 (04) :568-574
[10]   Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis [J].
Bowlus, Christopher L. ;
Karlsen, Tom H. ;
Broome, Ulrika ;
Thorsby, Erik ;
Vatn, Morten ;
Schrumpf, Erik ;
Lie, Benedicte A. ;
Boberg, Kirsten Muri .
JOURNAL OF HEPATOLOGY, 2006, 45 (05) :704-710